FibroBiologics converts $1.4M of notes, issues 2.15M shares at ~$0.65 avg price

FibroBiologics, Inc.

On June 20-27 and July 15, 2025, YA II PN converted $1.4M of Second and Third Notes into 2,154,530 common shares.
Conversion prices ranged from $0.5624 to $0.6934 per share; Second Note fully converted, Third Note has $3.9M remaining.
First Note retains full $5.0M principal; total remaining note balance across all three is $8.9M.
Shares issued in reliance on Section 4(a)(2) exemption; no public offering involved.

item 3.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.